1. Introduction {#sec1}
===============

The thyroid gland is a bilobar gland composed of two endocrine cells, namely, the thyroid follicular cells (TFCs) that produce the thyroid hormones T3 and T4 and the parafollicular cells that secrete calcitonin. TFCs are derived from the thyroid primordium, or thyroid anlage, that originates from a thickening of the endodermal epithelium in the foregut at the base of the prospective tongue. This structure develops the thyroid diverticulum that proliferates, invades the surrounding mesenchyme, and migrates through the anterior midline of the neck. During migration, the primitive thyroid acquires a bilobed structure while the thyroglossal duct, the initial connection to the primitive pharyngeal floor, loses its lumen and turns into disconnected fragments. When the developing thyroid reaches its final position at the base of the neck in front of the trachea, the fusion of the ultimobranchial bodies takes place to give rise to C cells. Finally, folliculogenesis occurs concomitantly with differentiation of thyroid progenitor cells into functional thyroid follicular cells, expressing specific thyroid genes such as TSH receptor (*TSHR*), Na/I symporter (*NIS*), and thyroglobulin (*TG*) \[[@B1]--[@B3]\].

In mouse models, normal embryogenesis of the thyroid was shown to be controlled by a well-integrated regulatory network of transcription factors \[[@B4], [@B5]\]. During the formation of the thyroid anlage (specification phase), the expression of thyroid transcription factors TITF1, PAX8, FOXE1, and HEX1 can be observed. FOXE1 is believed to be required for migration of the mouse thyroid primordium after detachment of the bud \[[@B6]\], and survival of the thyroid primordium depends on the expression of FOXE1 and PAX8 \[[@B4]\].

Ectopic thyroid is a rare malformation that results from a migration defect of the developing gland during embryogenesis \[[@B1]\]. The glands can be found at any point along the path of migration, from the foramen cecum to the mediastinum, and also in distal subdiaphragmatic areas. However, the most frequent site is at the base of the tongue or lingual thyroid \[[@B7]\]. Ectopia is the most common form of thyroid dysgenesis (TD) and congenital hypothyroidism \[[@B8], [@B9]\] but has also been detected in asymptomatic individuals or as a cause of hypothyroidism, dysphonia, dysphagia, cough, snoring, or sleep apnea and coexisting with a normally located thyroid \[[@B10]--[@B12]\] \[[@B13], [@B14]\].

The pathogenesis of ectopic thyroid, and the fact that some ectopic patients remain euthyroid throughout life, has not yet been elucidated. Few studies have characterized the expression of important thyroid proteins \[[@B10], [@B14]\]. In addition, mutations in genes *FOXE1*, *PAX8*, *TSHR*, *NKX2.1*, or *NKX2.5* associated with TD were identified in only 2-3% of TD cases \[[@B15]\]. Recently, with whole exome sequencing (WES), a powerful tool for investigating genetic causes of human diseases, novel genes were identified in TD cases \[[@B16], [@B17]\].

Thus, the aim of the present study was to investigate the histopathological and functional characteristics of human ectopic thyroid tissues through the expression of T4, specific thyroid proteins TG, NIS, TSHR, and thyroid transcription factors NKX2.1 and PAX8 by immunohistochemistry and to identify potential pathogenic mutations with expanded whole exome sequencing.

2. Material and Methods {#sec2}
=======================

2.1. Samples {#sec2.1}
------------

Paraffin blocks of four human ectopic thyroid samples were retrospectively collected from patients who underwent thyroid resection, and two flash-frozen tissue samples removed due to symptoms (sample 4) or suspicious cytology for papillary thyroid lesion (patient 2) were also included in the study. The control sample was taken from archived paraffin blocks of the normal thyroid. The study protocol was approved by the local Research Ethics Committees (HC 893/01 and CEP 1078/11).

2.2. Patients {#sec2.2}
-------------

All patients were born before the establishment of the mandatory Neonatal Screening Program in Brazil, except for patient 5. Clinicopathologic information on the ectopic patients was obtained from medical records. *Patient 1* is a 34-year-old female with an oropharyngeal ectopic thyroid mass detected at 7 years of age. The patient was never treated with levothyroxine (LT4) and had two cesarean deliveries. Preoperative thyroid hormonal status was TSH: 11.19 mIU/L (ref. 0.5--4.2 mIU/L), and total T4: 2.48 *μ*g/dL (ref. 5.3--12.6 *μ*g/dL) (to convert to nmol/L, multiply by 12.87). *Patient 2* is a 46-year-old female with ectopic thyroid located at the hyoid bone. The patient had been treated with LT4 (100 *μ*g/day) for hypothyroidism for the last 30 years. Goiter was diagnosed 4 years before surgery. *Patient 3* is a 7-year-old euthyroid girl. Lingual thyroid was detected at 5 years of age when investigating swallowing and sleeping difficulties. The patient was never treated with LT4. *Patient 4* is a 38-year-old male with lingual thyroid causing excessive snoring. The patient was never treated with LT4, and preoperative thyroid hormonal status was FT4: 0.6 ng/dL (ref. 0.6--1.54 ng/dL) (to convert to pmol/L, multiply by 12.87), TSH: 46.7 mIU/L (ref. 0.5--4.2 mIU/L), and negative anti-TPO and anti-Tg. *Patient 5* is a one-month-old girl with midline defect and lingual thyroid, diagnosed after surgery for suspected lingual tumor. Neonatal test after surgery indicated TSH \> 200 mIU/L. *Patient 6* is a 13-year-old girl with a neck nodule noted at birth that grew during childhood development. At 11 years of age, lingual thyroid was diagnosed and hypothyroidism confirmed with serum TSH: 11.42 mIU/L, FT4: 0.73 ng/dL (ref. 0.897--1.794 ng/dL), and negative anti-TPO. Levothyroxine was prescribed, but the patient showed poor compliance.

2.3. Immunohistochemistry {#sec2.3}
-------------------------

Three *μ*m thick sections of formalin-fixed and paraffin-embedded tissue samples from the six patients (samples 1--6) were first stained with hematoxylin/eosin for histological observation and then submitted to immunohistochemical procedures. Antigen retrieval was performed in 10 mM citrate buffer/pH 6.0 in a pressure cooker for three minutes, and endogenous peroxidase was inactivated in 6% hydrogen peroxide solution in an incubation step. The antibodies used in this study were monoclonal anti-thyroid peroxidase (TPO) (MoAb47, 1 : 500, DakoCytomation, Glostrup, Denmark), monoclonal anti-sodium-iodide symporter (NIS) (FP5A, 1 : 200, Mayo Clinic, USA), monoclonal anti-TTF1 (NKX2.1) (8G7G3/1, 1 : 500, Cell Marque, Rocklin, USA), monoclonal anti-thyroid-stimulating hormone receptor (TSHR) (4C1/E1/G8, 1 : 200, NeoMarkers, Fremont, USA), polyclonal anti-PAX8 (rabbit, 1 : 500, Cell Marque), polyclonal anti-thyroglobulin (rabbit, 1 : 400.000; DakoCytomation), and polyclonal anti-thyroxine (T4) (rabbit, 1 : 1.000; Cloud-Clone Corp., Houston, USA). Tissue sections were incubated overnight with the primary antibodies, and amplifications were obtained by peroxidase-conjugated polymer (Ultravision TL015-HDS, Thermo Fisher Scientific, Fremont, USA) and then revealed by diaminobenzidine/hydrogen peroxide substrate chromogen. Images were acquired using a Leica TCS SP8 microscope. The samples were examined by two of the authors.

2.4. Whole Exome Sequencing and Analysis {#sec2.4}
----------------------------------------

Total DNA from ectopic tissue from patients 2 and 4 was used to prepare the DNA library with Agilent SureSelectXT reagent kit (Agilent Technologies®, Santa Clara, USA), and the whole exome and UTR regions were sequenced in Illumina NextSeq 500 platform (Illumina® Inc., San Diego, USA) with a calculated coverage average of 140x per sample. Sequenced reads were aligned to a reference genome (GRCh37/hg19) using Burrows-Wheeler Alignment (BWA), and calling was performed with Genome Analysis Toolkit (GATK). Single nucleic variants and small insertions-deletions were annotated with ANNOVAR \[[@B18]\]. Data were filtered with 12 sample controls of Brazilian familial thyroid cancer tissues, variants with low-quality score, and common variants (MAF \> 1%), and neutral variants were eliminated. Predictions of deleterious effect were evaluated using online bioinformatics tools: SIFT, PolyPhen-2, mutationassessor, fathmm, Condel, MutationTaster, and PROVEAN \[[@B19]--[@B21]\].

3. Results {#sec3}
==========

3.1. Histopathology of Ectopic Thyroids {#sec3.1}
---------------------------------------

Fetal thyroid architecture was observed in sample 1 which exhibited isolated epithelial oval cells that were unpolarized or arranged in clusters and cords and primitive small follicles lined by cuboidal cells with a small lumen, some of them with colloid embedded in stroma (Figures [1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}). Small areas of the section with normal-sized follicles were also observed.

Histopathological examination of samples 2, 3, 4, and 6 revealed colloid goiter with highly enlarged follicles lined by flattened epithelial cells ([Figure 2(A)](#fig2){ref-type="fig"}). Focal areas (10--25%) composed of normal-sized follicles with cuboidal cells were also detected in these samples. Sample 5 showed normal thyroid tissue ([Figure 2(B)](#fig2){ref-type="fig"}).

3.2. Immunohistochemistry Expression {#sec3.2}
------------------------------------

TG expression was intense and diffuse in the lumen of all follicles of the samples under investigation, even in microfollicles from tissue with fetal architecture (sample 1). Cytoplasmic TG staining was weak or negative in the normal-sized follicles and also in the macrofollicles of the ectopic samples, similarly to normal thyroid sample. However, strong cytoplasmic staining was observed in isolated thyrocytes and microfollicles from the fetal thyroid tissue (sample 1) (Figures [1(a)](#fig1){ref-type="fig"}, [1(b)](#fig1){ref-type="fig"}, and [2](#fig2){ref-type="fig"}, a--c).

TPO staining was strong and diffuse within the cytoplasm of thyrocytes and was also observed in the apical membrane of all follicles of the ectopic samples examined, similar to normal thyroid tissue. Only cytoplasmic TPO was observed in isolated thyrocytes from fetal thyroid tissue (sample 1) (Figures [1(c)](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}, d--f).

TSHR expression was intense and scattered within the cytoplasm of thyrocytes of the ectopic samples, akin to a normal sample (Figures [1(d)](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}, g--i).

NKX2.1 diffuse immunostaining was strong in the majority of the nuclei of the ectopic thyroid samples, except for sample 2 which had approximately 10% low positive nuclei and scattered cytoplasmic expression. Low expression was observed in most of the nuclei of normal thyroid (Figures [1(e)](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}, j--l).

PAX8 moderate to intense diffuse expression was observed for all ectopic samples in approximately 70--80% of follicular cell nuclei, except for sample 2 which had a low expression in around 20% of nuclei and scattered cytoplasmic expression. Expression in normal thyroid tissue was low in most of the nuclei (Figures [1(f)](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}, m--o).

NIS was positive in the basolateral membrane in up to 10% of the cells of ectopic samples 3, 4, and 5. Cytoplasmic staining was observed in all samples. Normal thyroid sample had a similar pattern of 20% positivity in the basolateral membrane and cytoplasmic staining (Figures [1(g)](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}, p--r).

T4 expression was diffuse and intense in colloid of micro- and normal-sized follicles from the fetal thyroid sample ([Figure 1(h)](#fig1){ref-type="fig"}). In the other ectopic samples, the colloid T4 expression was moderate or intense, although some follicles showed low or negative immunostaining, similarly to normal thyroid ([Figure 2](#fig2){ref-type="fig"}, s--u).

3.3. Whole Exome Sequencing {#sec3.3}
---------------------------

After filtering the sequencing data, 3501 and 3287 variants (indel or SNVs) were identified in samples 2 and 4, respectively. The approaches to select deleterious mutations were (a) identification of common variants, (b) investigation of homozygous alterations (161 and 165, resp.) due to a possible recessive pattern of inheritance, (c) the candidate gene approach along with a list of 190 genes related to development and thyroid function ([Table 1](#tab1){ref-type="table"}) \[[@B22]--[@B34]\] because no family members were available, and (d) identification of variants in the 5\'UTRs of genes with binding motifs for FOXE1 ([Table 2](#tab2){ref-type="table"}) \[[@B35], [@B36]\] and PAX8 ([Table 3](#tab3){ref-type="table"}) \[[@B37]\] because these transcription factors are expressed from the early stages of thyroid embryogenesis. None of the selected variants were predicted deleterious by the specific programs. Thus, this analysis did not identify somatic mutations in the sequenced regions that could correlate with the disease.

4. Discussion {#sec4}
=============

Ectopic thyroid has a prevalence of 1 : 100,000--300,000 individuals and 1 : 4000--8000 among patients with thyroid disease \[[@B7]\] and is more frequent among females (65--80%) \[[@B38]\] while age at diagnosis ranges from the neonatal period to adult life. In terms of thyroid function, patients can present hypothyroid, euthyroidism, and, more rarely, hyperthyroidism \[[@B7], [@B14], [@B39]\].

In the present study, we investigated six ectopic thyroid samples: four were lingual thyroids, one was located at the oropharynx, and another at the hyoid bone. The histology of previously reported ectopic thyroid cases have shown a normal thyroid follicular pattern \[[@B10], [@B40]\] and a predisposition for similar abnormalities to those observed in normal-positioned glands, such as follicular adenoma, colloid goiter, and others \[[@B14], [@B41]--[@B45]\]. In the present study, the histopathological examination of the ectopic thyroid tissue from one adult patient (sample 1) disclosed an immature fetal architecture pattern characterized by the presence of clusters and cords of epithelial oval unpolarized cells, primitive follicles, and small follicles embedded in stroma with small areas of normal-sized follicles \[[@B27], [@B46]\]. Thyroid tissue with fetal-like appearance was previously identified in an apparently unaffected mother of congenital hypothyroid children associated with a heterozygous *PAX8* mutation \[[@B47]\]. Although no mutational investigation was performed, the immunohistochemistry examination showed strong nuclear PAX8 expression in around 80% of the cells of this tissue. It remains to be investigated whether this is a functional protein. The other ectopic samples exhibited normal thyroid features (sample 5) or colloid goiter patterns (samples 2, 3, 4, and 6).

All ectopic samples expressed T4 and the specific thyroid proteins TPO, TG, TSHR, PAX8, NKX2.1, and NIS, although focal follicles, tissue areas, or thyrocytes within follicles failed to express several of these proteins (data not shown). A heterogeneous expression pattern was also observed in normal thyroid tissues and has been related to morphological features and the ability of thyrocytes and follicles to concentrate iodine \[[@B48], [@B49]\]. Sample 2 had low nuclear expression of PAX8 and NKX2.1 and scattered cytoplasmic immunostaining; however, no somatic mutations were detected by WES. Both genes have been linked to thyroid development \[[@B3]\] and are expressed in the thyroid anlage when migration initiates \[[@B50]\], and mutations have been associated with few TD cases \[[@B51]\]. On the other hand, in ectopia, high PAX8 expression was associated to the activation state of the gland \[[@B22]\], and high expression of NKX2.1 was related to abnormal embryogenesis \[[@B14]\]. Thus, further studies assessing the significance of the observed data are warranted.

The location of the specific thyroid proteins was similar to that observed in normal thyroid \[[@B22], [@B52]\]. The cytoplasmic TSHR staining may have been due to the use of an antibody against the extracellular domain of this protein, as previously described \[[@B53]\]. Likewise, the cytoplasmic NIS localization in all the samples and the membrane immunostaining in four of them was in accordance with previous reports \[[@B27], [@B46], [@B54]\].

Previous transcriptome analysis showed no difference in the expression of specific thyroid genes between ectopic and normal thyroid tissue when corrected for TSH levels \[[@B22]\]. Despite the protein expression data not being corrected for TSH levels, our results confirm the expression and the appropriate localization of these proteins in ectopia, including T4. More interestingly, they confirm that primitive follicles in sample 1 were able to synthetize T4, asserting the functional status of the gland, although it may have been unable to respond to TSH.

The clinical data of the patients suggest that the ectopic thyroids have been able to synthetize adequate amounts of thyroid hormone at least early in the patient\'s life. Nevertheless, the amount of secreted thyroid hormone might not be sufficient to meet the body\'s needs during growth, promoting hypothyroidism, given that hormone requirement is based on body weight \[[@B55]\]. The low hormone production may be a consequence of the small size of the ectopic glands, possibly due to the migration defect, and of a limitation in TSH-induced growth \[[@B14]\].

Human thyroid morphogenesis begins at 22 days of pregnancy and is largely complete when reaching its final position in front of the trachea at 7 gestational weeks (GW) (48 days of pregnancy). At this point, the thyroid is composed of undifferentiated thyrocytes and expresses strong PAX8 and weak NKX2.1 and FOXE1 \[[@B2], [@B50]\]. Subsequently, the structural and functional differentiations of the thyroid ensue, accompanied by precisely timed expression of the specific thyroid genes and can be divided into three stages. First is the precolloid stage (7 to 10 GW), with a large number of cords or clusters of undifferentiated thyrocytes expressing PAX8, FOXE1, NKX2.1, and cytoplasmic TG and TSHR, while expression of NIS and TPO is not observed. Second is the beginning of the colloid stage (10 to 11 GW) with developing small follicles with polarizing thyrocytes that express TPO in the apical membrane, TSHR in the basolateral membrane, NIS in cytoplasm, and TG in follicular lumen and culminates with T4 synthesis. The third stage is the follicular growth stage (from 12 GW forth) with the basolateral membrane expression of NIS \[[@B27], [@B46]\]. Thus, our data allow us to hypothesize that at least three different impairments in thyroid development may have led to ectopic thyroid. In patient 1, a premature arrest of migration (33--48 days of gestation) may have led to positioning of the gland at the oropharyngeal level \[[@B1]\] with a subsequent arrest of the structural differentiation during the early colloid stage \[[@B1], [@B46]\], resulting in a nonhomogeneous fetal thyroid tissue pattern able to synthetize T4. Second, in patient 2, the migration of the developing gland may have also stopped before reaching its final position, resulting in the thyroid positioned at the hyoid bone, along with complete structural and functional differentiation. Third, the thyroid primordium may not have been able to detach from the pharyngeal floor and migrate, promoting a lingual thyroid with a complete structural and functional differentiation as observed in patients 3, 4, 5, and 6. Thus, the arrest of this process may have occurred earlier, at 26 days of gestation, when migration begins \[[@B1]\].

To assess potential somatic genetic causes of TD in protein-coding regions and 5\'UTRs, expanded exome analysis was performed in samples 2 and 4. Unfortunately the poor quality of the DNA from paraffin tissues from the other samples did not allow performing the genetic analysis. Despite the different exome-sequencing analysis approaches, no relevant somatic mutations were identified in the sequenced regions. A similar result was also obtained in a previous study that investigated somatic mutations in monozygotic twins discordant to TD \[[@B56]\]. On the other hand, WES identified novel missense mutations in the BOREALIN gene in a consanguineous family with TD \[[@B16]\] and DUOX2 mutations in the N-terminal domain that may play a role in thyroid development in sporadic TD cases \[[@B17]\], confirming the genetic heterogeneity of this pathology. Furthermore, the involvement of other genetic mechanisms may be also considered. Novel copy number variations (CNVs), not described in the healthy population, were identified in 8.75% of 80 TD patients \[[@B54], [@B56]\]. No differences in the CpG island methylation of promoter regions were observed between normal eutopic and ectopic thyroid tissues \[[@B22], [@B57]\]. Thus, the cause of TD could be associated with molecular alterations in other regions of the genoma or with polygenic or other epigenetic alterations, or it could be purely stochastic.

In conclusion, no somatic mutations in the sequenced regions were associated with ectopic thyroid. This is the first description of fetal histopathological architecture in an adult ectopic thyroid due to the arrest of structural differentiation of the developing gland along with the arrest of migration that proved able to synthesize thyroid hormone but not to respond to TSH. We showed the ability of the ectopic thyroids to express specific thyroid genes and T4, despite the migratory and histological differentiation defects, as well as the ability to synthesize the thyroid hormone for at least some period of the patient\'s life.
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![Hematoxylin/eosin staining (a) (10x) and immunohistochemistry expression of specific thyroid genes in ectopic thyroid tissue sample 1 showing fetal architecture with clusters, cords and isolated epithelial oval cells, small follicles lined by cuboidal cells, and small areas of normal-sized follicles (b--h) (40x). TG: intense diffuse expression in the lumen of follicles and in cytoplasm of microfollicles and isolated thyrocytes (b). TPO: intense immunostaining in the apical membrane of micro- and normal-sized follicles; cytoplasmic TPO was observed in follicular cells and isolated thyrocytes (c). TSHR: scattered staining in the cytoplasm of thyrocytes (d). NKX2.1: strong diffuse nuclear immunostaining observed in most nuclei (e). PAX8: moderate or intense expression observed in around 80% of nuclei (f). NIS: diffuse cytoplasmic staining observed (g). Thyroxine (T4): diffuse and intense expression observed in the colloid of micro- and normal-sized follicles (h).](IJE2018-4682876.001){#fig1}

![Immunohistochemistry expression of specific thyroid genes in ectopic and normal thyroid tissue. (A) Representative images of samples 2, 3, 4, and 6 showing goiter; (B) sample 5 exhibiting normal thyroid pattern; and (C) normal thyroid sample. TG: intense diffuse TG expression in the lumen of all follicles of the ectopic and normal samples; weak or negative cytoplasmic staining in cell follicles (a--c). TPO: intense immunostaining in the cytoplasm of thyrocytes and in the apical membrane of the follicles of ectopic samples examined, similar to the normal thyroid sample (d--f). TSHR: scattered staining in the cytoplasm of thyrocytes in ectopic and normal samples (g--i); magnified representative image showing basolateral membrane staining in some cells. NKX2.1: strong diffuse nuclear immunostaining was observed in most of the nuclei of the ectopic and normal thyroid tissues (j--l), except for sample 2, showing 10% positive nuclei. PAX8: moderate expression observed in around 80% of nuclei of normal and ectopic thyroid tissues (m--o) with focal areas of low nuclear expression in the ectopic samples. In sample 2, only 20% of positive nuclei were positive and scattered cytoplasmic expression was also observed. NIS: cytoplasmic staining was observed in all samples (p--r), and basolateral membrane positivity was observed in up to 10% of cells of samples 3, 4, and 5 (p, q). Normal samples had a similar pattern of 20% positivity in the basolateral membrane and cytoplasmic staining (r). Thyroxine (T4): moderate or intense diffuse expression in follicular colloid was observed, although some follicles showed low immunostaining, similar to the normal thyroid (s--u). Magnification at 40x except for the images of a, c, s, and u at 20x.](IJE2018-4682876.002){#fig2}

###### 

Candidate genes related to development and thyroid function (gene symbol) \[[@B22]--[@B34]\].

  ---------- ---------- ---------- --------- ----------
  ABCA13     DIO2       FOXE3      KDR       SFRP1
  ACP2       DKK3       FOXQ1      KLF4      SFRP2
  ACTA1      DMD        FRS2       KPNA4     SFRS2
  AKT1       DTX4       FRS2A      LAMA4     SHH
  AKT3       DUOX1      FRZB       LEFTY1    SIX1
  ANKRD36B   DUOX2      FXR1       LHX3      SLC26A4
  ARHGEF6    DUOXA1     FZD1       LHX4      SLC5A5
  ASPM       DUOXA2     FZD3       LMO3      SMAD3
  ATP2A1     DUSP6      FZD4       LRP8      SMAD5
  BCL2L1     EDN1       GATA5      LYZ       SMAD9
  BCL2L12    EDN3       GJA1       MKI67     SMOC2
  BGN        EEF1A2     GLIS3      MKRN1     SNX1
  BMP4       EFNB2      GNG5       MS4A6A    SOX17
  C9orf70    EGFR       GPNMB      MTHFD2    SOX9
  CCND1      EGR1       GSTT1      MUC1      SPRED1
  CDC42EP4   EMP3       HADHA      MYBPC1    TAL1
  CDH16      ENO3       HAND2      MYL2      TAZ
  CDH2       EVC2       HES1       NAV1      TBX1
  CEBPB      EYA1       HESX1      NKX2.1    TCAP
  CECR1      FAU        HHEX       NKX2.5    TCF4
  CFC1B      FBLN1      HLA-DQA1   NLK       TEF
  CGA        FGF10      HLA-DQB1   PABPC1    TG
  CHGA       FGF12      HOXA2      PAX2      TGFB2
  CHORDC1    FGF2       HOXA3      PAX8      THRA
  CKM        FGF3       HOXA5      PBX4      THRB
  CLDN5      FGF8       HOXB3      PCSK2     THRSP
  CNTN6      FGFR1      HOXD3      PITX2     TNFAIP2
  COL1A1     FGFR2      HSPA1B     PKNOX1    TNFRSF21
  COL3A1     FGL2       IGHG4      PLCXD1    TNNC2
  CPEB4      FLJ11127   IGJ        PLEKHA3   TPO
  CREB1      FLJ32115   IGSF1      PLXND1    TRA
  CTGF       FMR1       INHBB      POLD4     TRH
  CTNNAL1    FN1        INSL3      PRKCE     TSHb
  CXCL12     FOS        ISL1       PROP1     TSHR
  CXCR4      FOSB       ISL2       RARRES1   TWSG1
  CYBB       FOXA1      IYD        RASD1     TXNIP
  CYBRD1     FOXA2      JAG1       RNASE6    TYROBP
  DIO1       FOXE1      JAG3       ROBO4     VEGFA
  ---------- ---------- ---------- --------- ----------

###### 

Target genes of the transcription factor FOXE1 (gene symbol) \[[@B35], [@B36]\].

  --------- --------- --------- -------- ---------
  ADAMTS9   CRIP2     ENGASE    IL23A    RT1-DA
  AHCY      CTGF      ERO1LB    KRT20    S100A4
  AMIGO3    DDIT3     ETV5      MANF     SDF2L1
  ANKRD37   DERL3     FGF18     MFSD2    SEC23B
  ATMIN     DNAJB11   FOLR1     NR4A2    SEL1L
  BCAM      DNAJB9    GGCT      NUPR1    SLIT1
  BET1      DNAJC3    GMPPB     PDIA4    TM4SF1
  CASP4     DUOX2     HSP90B1   PRIMA1   TMEM140
  CDH1      DUSP5     HSPA5     PRSS8    TMEM66
  COQ10B    DYNLRB2   HYOU1     RIL      ZFAND2A
  CRELD2    ELOVL2    IGF2BP2   RIOK3    
  --------- --------- --------- -------- ---------

###### 

Target genes of the transcription factor PAX8 (gene symbol) \[[@B37]\].

  ---------- -------- --------- ---------- ---------
  ACOT2      CFD      GCSH      LACTB      RASSF2
  ACY1       CITED2   GJA4      LRP8       RSAD2
  ADAMTS9    CRYAB    GSTP1     LRRC58     RUNX2
  ALCAM      CTGF     HACD4     NFKB1      SLC26A7
  ANKRD9     CXCL1    HSD17B1   NR3C2      SMIM22
  ARHGAP22   DGAT2    IGFBP5    NRIP3      SPARC
  BHLHE40    EGR1     IGFBP7    NUP107     STS
  BRAF       EIF4E    IRGQ      OPRK1      TAZ
  CAMK1G     ENPP1    JUN       OSTALPHA   TEKT4
  CAMKK2     F10      KCNJ15    PBLD       TG
  CD47       FAM13A   KCNJ16    POMT1      TMEM140
  CDA        FGFR2    KCNK1     PRR5L      TRIB1
  CDH16      FOXE1    KRT14     RAB17      WBP2
  CDH16      GALK2    KRT7      RASL10A    WNT4
  ---------- -------- --------- ---------- ---------
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